Skip to main content
SpringerLink
Log in

Use and Toxicity of the Colony-Stimulating Factors

  • Review Article
  • Drug Experience
  • Published:
Drug Safety Aims and scope Submit manuscript

Summary

The colony-stimulating factors (CSFs) have emerged as effective drugs in a variety of clinical situations. These drugs stimulate the production and activity of haematopoietic cells in vitro and in vivo. Two members of this group, granulocyte CSF (G-CSF) and granulocyte-macrophage CSF (GM-CSF), have been approved in the US and Europe for use following cytotoxic chemotherapy and autologous bone marrow transplantation. Other uses of the CSFs include myelodysplastic syndromes, aplastic anaemia, the acquired immunodeficiency syndrome (AIDS) and cyclic and congenital neutropenias.

Although CSFs have generally been well tolerated in clinical use there are a number of theoretical concerns, including disease acceleration, biased stem cell commitment and bone marrow exhaustion.

New CSFs are currently under development. Combinations of growth factors in the future may maximise effectiveness while minimising toxicity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Advani R, Chao NJ, Horning SJ, Blume KG, Ahn DK, et al. Granulocyte macrophage colony-stimulating factor (GM-CSF) as an adjunct to autologous hemopoietic stem cell transplantation for lymphoma. Annals of Internal Medicine 116: 183–189, 1992

    PubMed  CAS  Google Scholar 

  • Andrews R, Knitter G, Bartelmez S, Langley K, Farar D, et al. Recombinant human stem cell factor, a c-kit ligand stimulates hematopoiesis in primates. Blood 78: 1975–1980, 1991

    PubMed  CAS  Google Scholar 

  • Antin JH, Smith BR, Holmes W, Rosenthal DS. Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor in aplastic anemia and myelodysplastic syndrome. Blood 72: 705–713, 1988

    PubMed  CAS  Google Scholar 

  • Antman KS, Griffin JD, Elias A, Socinski MA, Ryan L, et al. Effect of recombinant human granulocyte-macrophage colony stimulating factor on chemotherapy induced myelosuppression. New England Journal of Medicine 319: 593–598, 1988

    Article  PubMed  CAS  Google Scholar 

  • Baldwin GC, Gasson JC, Kaufman SE, Quan SG, Williams RE, et al. Nonhematopoietic tumor cells express functional CSF receptors. Blood 73: 1033–1037, 1989

    PubMed  CAS  Google Scholar 

  • Baldwin G, Golde D, Widhopf G, Economou J, Gasson J. Identification and characterization of a low affinity granulocyte macrophage colony stimulating factor receptor on primary and cultured human melanoma cells. Blood 78: 609–615, 1991

    PubMed  CAS  Google Scholar 

  • Begley CG, Metcalf D, Nicola NA. Primary human myeloid leukemia cells: comparative responsiveness to proliferative stimulation by GM-CSF or G-CSF and membrane expression of CSF receptors. Leukemia 1: 1–8, 1987

    PubMed  CAS  Google Scholar 

  • Berdel WE, Danhauser-Riedl S, Steinhauser G, Winton EF. Various human hematopoietic growth factors (interleukin-2, GM-CSF, G-CSF) stimulate clonal growth of nonhematopoietic tumor cells. Blood 73: 80–83, 1989

    PubMed  CAS  Google Scholar 

  • Bernstein ID, Andrews RG, Zsebo KM. Recombinant human stem cell factor enhances the formation of colonies by CD34+ and CD34+lin- cells and the generation of colony-forming cell progeny from CD34+lin- cells cultured with IL-3, G-CSF or GM-CSF. Blood 77: 2316–2321, 1991

    PubMed  CAS  Google Scholar 

  • Bettelheim P, Valent P, Andreeff M, Tafuri A, Haimi J, et al. Recombinant human granulocyte-macrophage colony-stimulating factor in combination with standard induction chemotherapy in de novo acute myeloid leukemia. Blood 77: 700–711, 1991

    PubMed  CAS  Google Scholar 

  • Bonilla MA, Gillio AP, Ruggeiro M, Kernan NA, Brochstein JA, et al. Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranylocytosis. New England Journal of Medicine 320: 1574–1580, 1989

    Article  PubMed  CAS  Google Scholar 

  • Brandt SJ, Peters WP, Atwater SK, Kurtzberg J, Borowitz MJ, et al. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. New England Journal of Medicine 318: 869–876, 1988

    Article  PubMed  CAS  Google Scholar 

  • Bronchud MH, Scarffe JH, Thatcher N, Crowther D, Souza LM, et al. Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer. British Journal of Cancer 36: 809–813, 1987

    Article  Google Scholar 

  • Buchner T, Hiddemann W, Koenigsmann M, Zuhlsdorf M, Wormann B, et al. Recombinant human granulocyte-macrophage colony stimulating factor after chemotherapy in patients with acute myeloid leukemia at higher age or after relapse. Blood 78: 1190–1197, 1991

    PubMed  CAS  Google Scholar 

  • Champlin RE, Nimer SD, Ireland P, Oette DH, Golde DW. Treatment of refractory aplastic anemia with recombinant human granulocyte-macrophage colony-stimulating factor. Blood 73: 694–699, 1989

    PubMed  CAS  Google Scholar 

  • Crawford J, Ozer H, Stoller R, Johnson D, Lyman G, et al. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. New England Journal of Medicine 315: 164–170, 1991

    Article  Google Scholar 

  • Demetri GD, Griffin JD. Granulocyte colony-stimulating factor and its receptor. Blood 78: 2791–2808, 1991

    PubMed  CAS  Google Scholar 

  • De Vries EGE, Willemse PHB, Biemsa B, Stern AC, Limburg PC, et al. Flare-up of rheumatoid arthritis during GM-CSF treatment after chemotherapy. Lancet 338: 517–518, 1991

    Article  PubMed  Google Scholar 

  • Dewitte T, Gratwohl A, Van Der Lely N, Bacigalupo A, Stern AC, et al. Recombinant human granulocyte-macrophage colony-stimulating factor accelerates neutrophil and monocyte recovery after allogeneic T-cell depleted bone marrow transplantation. Blood 79: 1359–1365, 1992

    CAS  Google Scholar 

  • Estey EH, Dixon D, Kantarjian HM, Keating MJ, McCredie K, et al. Treatment of poor-prognosis, newly diagnosed acute myeloid leukemia with Ara-C and recombinant human granulocyte-macrophage colony stimulating factor. Blood 75: 1766–1769, 1990

    PubMed  CAS  Google Scholar 

  • Gabrilove JL, Jakubowski A, Scher H, Sternberg Wong G, et al. Effect of granulocyte colony stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional cell carcinoma of the urothelium. New England Journal of Medicine 318: 1414–1422, 1988

    Article  PubMed  CAS  Google Scholar 

  • Ganser A, Lindemann A, Seipelt G, Ottmann O, Eder M, et al. Effects of recombinant human interleukin-3 in aplastic anemia. Blood 76: 1287–1292, 1990c

    PubMed  CAS  Google Scholar 

  • Ganser A, Lindemann A, Seipelt G, Ottmann Herrmann F, et al. Effects of recombinant human interleukin-3 in patients with normal hematopoiesis and in patients with bone marrow failure. Blood 76: 666–676, 1990b

    PubMed  CAS  Google Scholar 

  • Ganser A, Seipelt G, Lindemann A, Ottmann O, Faik S, et al. Effect of recombinant human interleukin-3 in patients with myelodysplastic syndromes. Blood 76: 455–462, 1990a

    PubMed  CAS  Google Scholar 

  • Ganser A, Volkers Greher J, Ottmann OG, Walther F, et al. Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes — a phase I/II trial. Blood 76: 31–37, 1989

    Google Scholar 

  • Gasson JC. Molecular physiology of granulocyte-macrophage colony-stimulating factor. Blood 77: 1131–1145, 1991

    PubMed  CAS  Google Scholar 

  • Gianni AM, Siena S, Bregni M, Tarella C, Stern AC, et al. Granulocyte-macrophage colony-stimulating factor to harvest circulating hematopoietic stem cells for autotransplantation. Lancet 2: 580–584, 1989

    Article  PubMed  CAS  Google Scholar 

  • Gianni AM, Tarella C, Siena S, Bregni M, Boccadoro M, et al. Durable and complete engraftment of rhGM-CSF exposed peripheral blood progenitor cells. Bone Marrow Transplantation 6: 143–145, 1990

    PubMed  CAS  Google Scholar 

  • Glaspy JA, Baldwin GC, Robertson PA, Souza L, Vincent M, et al. Therapy for neutropenia in hairy cell leukemia with recombinant human granulocyte colony-timulating factor. Annals of Internal Medicine 110: 789–795, 1988

    Google Scholar 

  • Greenberg PL. The smoldering myeloid leukemia states: clinical and biologic features. Blood 61: 1035–1044, 1983

    PubMed  CAS  Google Scholar 

  • Griffin JD. Clinical applications of colony-stimulating factors. Oncology 2: 15–21, 1988

    PubMed  CAS  Google Scholar 

  • Griffin JD, Young D, Herrmann F, Wiper D, Wagner K, et al. Effects of recombinant GM-CSF on proliferation of clonogenic cells in acute myeloblastic leukemia. Blood 67: 1448–1453, 1986

    PubMed  CAS  Google Scholar 

  • Guinan E, Sieff Oette D, Nathan D. A phase I/II trial of recombinant granulocyte-macrophage colony-stimulating factor for children with aplastic anemia. Blood 76: 1077–1082, 1990

    PubMed  CAS  Google Scholar 

  • Gulati SC, Bennett CL. Granulocyte-macrophage colony-stimulating factor (GM-CSF) as adjunct therapy in relapsed Hodgkin disease. Annals of Internal Medicine 116: 177–182, 1992

    PubMed  CAS  Google Scholar 

  • Hammond WP, Price TH, Souza LM, Dale DC. Treatment of cyclic neutropenia with granulocyte colony-stimulating factor. New England Journal of Medicine 320: 1306–1311, 1989

    Article  PubMed  Google Scholar 

  • Herrmann F, Lindemann A, Klein H, Lubbert M, Schulz G, et al. Effect of recombinant granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome with excess blasts. Leukemia 3: 335–338, 1989

    PubMed  CAS  Google Scholar 

  • Hoang T, Nara N, Wong G, Clark S, Minden MD, et al. Effects of recombinant GM-CSF on the blast cells of acute myeloblastic leukemia. Blood 68: 313–316, 1986

    PubMed  CAS  Google Scholar 

  • Kitano K, Abboud C, Ryan D, Quan S, Baldwin G, et al. Macrophage-active colony stimulating factors enhance human immunodeficiency virus type 1 infection in bone marrow stem cells. Blood 77: 1699–1705, 1991

    PubMed  CAS  Google Scholar 

  • Kojima S, Fukuda M, Miyajima Y, Matsuyama T, Horibe K. Treatment of aplastic anemia in children with recombinant human granulocyte colony stimulating factor. Blood 77: 937–941, 1991

    PubMed  CAS  Google Scholar 

  • Kuzrock R, Talpaz M, Estior Z, Rosenblum MG, Gutterman JU. Phase I study of recombinant human interleukin-3 in patients with bone marrow failure. Journal of Clinical Oncology 9: 1241–1250, 1991

    Google Scholar 

  • Leary AG, Yang Y-C, Clark SC, Gasson J, Golde D, et al. Recombinant gibbon interleukin-3 supports formation of human multilineage colonies and blast cell colonies in culture: comparison with recombinant human granulocyte-macrophage colony-stimulating factor. Blood 70: 1343–1348, 1987

    PubMed  CAS  Google Scholar 

  • Levine J, Allan J, Tessitore J, Falcone N, Galasso F, et al. Recombinant human granulocyte-macrophage colony stimulating factor ameliorates zidovudine induced neutropenia in patients with acquired immunodeficiency syndrome (AIDS), AIDS related complex. Blood 78: 3148–3154, 1991

    PubMed  CAS  Google Scholar 

  • Lieschke G, Cebon J, Morstyn G. Characterization of the clinical effects after the first dose of bacterially synthesized recombinant human granulocyte-macrophage colony stimulating factor. Blood 74: 2634–2643, 1989b

    PubMed  CAS  Google Scholar 

  • Lieschke G, Maher D, Cebon J, Os’Connor M, Green M, et al. Effects of bacterially synthesized recombinant human granulocyte macrophage colony stimulating factor in patients with advanced malignancy. Annals of Internal Medicine 110: 357–364, 1989a

    PubMed  CAS  Google Scholar 

  • Lindemann A, Ganser F, Herrmann F, Frisch J, Seipelt G, et al. Biologic effects of recombinant human interleukin-3 in vivo. Journal of Clinical Oncology 9: 2120–2127, 1991

    PubMed  CAS  Google Scholar 

  • Lindemann A, Herrmann F, Oster W, Haffner G, Meyenburg, et al. Hematologic effects of recombinant human granulocyte colony stimulating factor in patients with malignancy. Blood 74: 2644–2651, 1989

    PubMed  CAS  Google Scholar 

  • Martin FH, Suggs SV, Langley KE, Lu HS, Ting J, et al. Primary structure and functional expression of rat and human stem cell factor DNAs. Cell 63: 203–211, 1990

    Article  PubMed  CAS  Google Scholar 

  • Masaoka T, Takaku F, Kato S, Moriyama Y, Rodera Y, et al. Recombinant human granulocyte colony stimulating factor in allogeneic bone marrow transplant. Experimental Haematology 17: 1047–1050, 1989

    CAS  Google Scholar 

  • Molineux G, Pojda Z, Hampson J, Lord B, Dexter TM. Trans-plantation potential of peripheral blood stem cells induced by granulocyte colony stimulating factor. Blood 76: 2153–2158, 1990

    PubMed  CAS  Google Scholar 

  • Morstyn G, Souza LM, Keech J, Sheridan W, Campbell L, et al. Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet 1: 667–672, 1988

    Article  PubMed  CAS  Google Scholar 

  • Motoji T, Takanashi M, Fuchinoue M, Masuda M, Oshimi K, et al. Effect of recombinant GM-CSF and recombinant G-CSF on colony formation of blast progenitors in acute myeloblastic leukemia. Experimental Haematology 17: 56–60, 1989

    CAS  Google Scholar 

  • Nathan FE, Besa EC. GM-CSF and accelerated hemolysis. (Erratum, New England Journal of Medicine 326: 904, 1992.) New England Journal of Medicine 326: 417, 1992

    PubMed  CAS  Google Scholar 

  • Negrin RS, Haeuber DH, Nagler A, Kobayashi Y, Sklar J, et al. Maintenance treatment of patients with myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factor. Blood 76: 36–43, 1990

    PubMed  CAS  Google Scholar 

  • Negrin RS, Haeuber DH, Nagler A, Olds LC, Donlon T, et al. Treatment of myelodysplastic syndromes with recombinant human granulocyte-colony-stimulating factor. A phase I/II trial. Annals of Internal Medicine 110: 976–985, 1989

    PubMed  CAS  Google Scholar 

  • Nemunaitis J, Buckner CD, Appelbaum FR, Higano CS, Mori M, et al. Phase I/II trial of recombinant human granulocyte-macrophage colony stimulating factor following allogeneic bone marrow transplantation. Blood 77: 2065–2071, 1991a

    PubMed  CAS  Google Scholar 

  • Nemunaitis J, Rabinowe SN, Singer JW, Bierman PJ, Vose JM, et al. Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer. New England Journal of Medicine 324: 1773–1778, 1991b

    Article  PubMed  CAS  Google Scholar 

  • Nemunaitis J, Singer JW, Buckner CD, Durnam D, Epstein C, et al. Use of recombinant human granulocyte-macrophage colony-stimulating factor in graft failure after bone marrow transplantation. Blood 76: 245–253, 1990

    PubMed  CAS  Google Scholar 

  • Nemunaitis J, Singer JW, Buckner CD, Hill R, Storb R, et al. Use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous marrow transplantation for lymphoid malignancies. Blood 72: 834–836, 1988

    PubMed  CAS  Google Scholar 

  • Nissen Tichelli A, Gratwohl A, Speck B, Milne A, et al. Failure of recombinant human granulocyte-macrophage colony-stimulating factor therapy in aplastic anemia patients with very severe neutropenia. Blood 72: 2045–2047, 1988

    Google Scholar 

  • Ohno R, Tomonaga M, Kobayashi T, Kanamaru A, Shirakawa S, et al. Effect of granulocyte colony-stimulating factor after intensive induction therapy in relapsed or refractory acute leukemia. New England Journal of Medicine 323: 871–877, 1990

    Article  PubMed  CAS  Google Scholar 

  • Powles R, Smith C, Milan S, Treleaven J, Millar J, et al. Human recombinant GM-CSF in allogeneic bone marrow transplantation for leukaemia: Double-blind, placebocontrolled trial. Lancet 2: 1417–1420, 1990

    Article  Google Scholar 

  • Salmon SE, Liu R. Effects of granulocyte-macrophage colony-stimulating factor on in vitro growth of human solid tumors. Journal of Clinical Oncology 7: 1346–1350, 1989

    PubMed  CAS  Google Scholar 

  • Sealand S, Caux C, Favre C, Aubry P, Mannoni P, et al. Effects of recombinant human interleukin 3 on CD34-enriched normal hematopoietic progenitors and on myeloblastic leukemia cells. Blood 72: 1580–1588, 1988

    Google Scholar 

  • Sheridan WP, Begley CG, Juttner CA, Szer J, To LB, et al. Effect of peripheral blood progenitor cells mobilized by filgrastim (G-CSF) on platelet recovery after high dose chemotherapy. Lancet 339: 640–644, 1992

    Article  PubMed  CAS  Google Scholar 

  • Sheridan WP, Morstyn G, Wolf M, Dodds A, Lusk J. Granulocyte colony-stimulating factor and neutrophil recover after high-dose chemotherapy and autologous bone marrow transplantation. Lancet 2: 891–895, 1989

    Article  PubMed  CAS  Google Scholar 

  • Siena S, Bregni M, Brando B, Belli N, Ravagnani F, et al. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 77: 400–409, 1991

    PubMed  CAS  Google Scholar 

  • Siena S, Bregni M, Brando M, Ravagnani F, Bonadonna G, et al. Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: Enhancement by intravenous recombinant human granulocyte macrophage colony-stimulating factor. Blood 74: 1905–1914, 1989

    PubMed  CAS  Google Scholar 

  • Sonoda Y, Yang Y-C, Wong GG, et al. Analysis in serum free culture of targets of recombinant human hematopoietic growth factors: Interleukin 3 and granulocyte/macrophage-colony-stimulating factor are specific for developmental stages. Proceedings of the National Academy of Sciences of the United States of America 85: 4360–4364, 1988

    Article  PubMed  CAS  Google Scholar 

  • Sonoda Y, Yashige H, Fuuii H, Tsuda S, Maekawa T, et al. Bilineage response in refractory aplastic anemia patients following long-term administration of recombinant human granulocyte colony-stimulating factor. European Journal of Haematology 48: 41–48, 1992

    Article  PubMed  CAS  Google Scholar 

  • Stephens L, Haire WD, Kotulak G, Schmit-Pokory K, Kessinger A. Granulocyte macrophage colony stimulating factor in peripheral stem cell collection for transplantation: high incidence of apheresis catheter thrombosis. Abstract no. D209. Journal of Cellular Biochemistry (Suppl. 16A): 191, 1992

  • Steward WP, Scarffe JH, Austin R, Bonnern E, Thatcher N, et al. Recombinant human granulocyte macrophage colony stimulating factor given as daily short infusions — a phase I dose toxicity study. British Journal of Cancer 59: 142–145, 1989

    Article  PubMed  CAS  Google Scholar 

  • Steward WP, Scarffe JH, Dirix LY, Chang J, Radford J, et al. Granulocyte-macrophage colony stimulating factor (GM-CSF) after high-dose melphalan in patients with advanced colon carcinoma. British Journal of Cancer 61: 749–754, 1990

    Article  PubMed  CAS  Google Scholar 

  • Taylor K, Jagannath S, Spitzer G, Spinolo J, Tucker S, et al. Recombinant human granulocyte colony stimulating factor hastens granulocyte recovery after high dose chemotherapy and autologous bone marrow transplantation in Hodgkins’s disease. Journal of Clinical Oncology 7: 1791–1799, 1989

    PubMed  CAS  Google Scholar 

  • Thompson JA, Lee DJ, Kidd P, Rubin E, Kaufmann J, et al. Subcutaneous granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome: toxicity, pharmacokinetics and hematologic effects. Journal of Clinical Oncology 7: 629–637, 1989

    PubMed  CAS  Google Scholar 

  • Vadhan-Raj S, Buescher S, Broxmeyer HE, LeMaistre A, Lepe-Zuniga JL, et al. Stimulation ot myelopoiesis in patients with aplastic anemia by recombinant human granulocyte-macrophage colony-stimulating factor. New England Journal of Medicine 319: 1628–1634, 1988

    Article  PubMed  CAS  Google Scholar 

  • Vadhan-Raj S, Keating K, LeMaistre A, Hittelman WN, McCredie K, et al. Effects of recombinant human granulocyte-macrophage colony stimulating factor in patients with myelodysplastic syndromes. New England Journal of Medicine 317: 1545–1552, 1987

    Article  PubMed  CAS  Google Scholar 

  • Van Der Wouw P, Van Leeuwen R, Van Oers R, Lange J, Danner S. Effects of recombinancy human granulocyte colony stimulating factor on leucopenia in zidovudine-treated patients with AIDS and AIDS related complex, a phase I/II study. British Journal of Haematology 78: 319–324, 1991

    Article  PubMed  Google Scholar 

  • Vellenga E, Young DC, Wagner K, Wiper D, Ostapovicz D, et al. The effect of GM-CSF and G-CSF in promoting growth of clonogenic cells in acute myeloblastic leukemia. Blood 69: 1771–1776, 1987

    PubMed  CAS  Google Scholar 

  • Weite K, Zeidler C, Reiter A, Muller W, Odenwald E, et al. Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia. Blood 75: 1056–1063, 1990

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Bone Marrow Transplant Program, Department of Medicine (Hematology), Stanford University Hospital, Room H1353, Stanford, California, 94305, USA

    Jeffrey R. Schriber &  Robert S. Negrin

Authors
  1. Jeffrey R. Schriber
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert S. Negrin
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schriber, J.R., Negrin, R.S. Use and Toxicity of the Colony-Stimulating Factors. Drug-Safety 8, 457–468 (1993). https://doi.org/10.2165/00002018-199308060-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-199308060-00006

Keywords

Search

Navigation